There are five distinct molecular subtypes of breast cancer: luminal A and B, human epidermal growth factor receptor 2 (HER2)-enriched, basal-like and claudin-low (3), with the last 2 being subcategories of triple-negative breast cancer (Figure 1). This evidence concerns the gene ERBB2 and breast carcinoma.